It is reported that the abnormal expression of MSH2 is related to cancers such as oral squamous cell carcinoma, primary prostate cancer, breast cancer, and gastric cancer [18–21]. This evidence concerns the gene MSH2 and oral cavity squamous cell carcinoma.